首頁 > 市場調查報告書 > 製藥

神經疾病

市場調查報告書

商品編碼

1578245

全球肌萎縮側索硬化症治療市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Amyotrophic Lateral Sclerosis Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年09月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球肌萎縮側索硬化症治療市場的需求預計將從2023年的7.7307億美元達到2032年的近13.4428億美元，2024-2032年研究期間的複合年成長率為6.34%。

肌萎縮側索硬化症是一種加速性神經退化性疾病，其中調節中樞神經系統隨意肌的神經細胞死亡。在近一半的 ALS 病例中，患者會喪失吞嚥、呼吸、說話、行走和使用雙手的能力。肌萎縮側索硬化症無法治愈，沒有有效的治療方法可以減緩或阻止其病程。儘管沒有任何治療可以消除肌萎縮側索硬化症造成的損害，但它可以透過減少症狀的進展、預防併發症和提高整體生活品質，讓人們感到更加安心和獨立。 ALS 可以透過物理和職業治療、溝通幫助、營養支持和呼吸支持來治療。

市場動態

久坐的生活方式會增加老年人患這種疾病的機會，因此需要開發新的藥物和量身定做的治療方案。預計這些因素將推動肌萎縮側索硬化症治療市場走高。肌萎縮側索硬化症盛行率的成長預計將推動全球肌萎縮側索硬化症治療市場的發展。然而，預計該市場將受到高昂的治療成本、對肌萎縮側索硬化症缺乏了解以及有限的治療方案的阻礙。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球肌萎縮側索硬化症治療市場的各個細分市場進行了包容性評估。肌萎縮側索硬化症治療產業的成長和趨勢為本研究提供了整體方法。

市場區隔

肌萎縮側索硬化症治療市場報告的這一部分提供了國家和區域層面的細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按治療

藥物
幹細胞治療
其他

按配銷通路

醫院藥房
零售藥局
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲肌萎縮側索硬化症治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。肌萎縮側索硬化症治療市場的主要參與者包括田邊三菱製藥公司、大塚製藥有限公司、BrainStorm Therapeutics、Biogen Inc.、Corestem、AB Science、F.Hoffmann-La Roche AG、Biohaven Pharmaceutical、Sun Pharmaceutical 、Ionis製藥公司。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：肌萎縮側索硬化症治療公司的競爭格局

肌萎縮側索硬化症治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Mitsubishi Tanabe Pharma Corporation

公司概況
公司收入
產品
最新動態

Otsuka Pharmaceutical Co. Ltd.

公司概況
公司收入
產品
最新動態

BrainStorm Therapeutics

公司概況
公司收入
產品
最新動態

Biogen Inc.

公司概況
公司收入
產品
最新動態

Corestem

公司概況
公司收入
產品
最新動態

AB Science

公司概況
公司收入
產品
最新動態

F.Hoffmann-La Roche AG

公司概況
公司收入
產品
最新動態

Biohaven Pharmaceutical

公司概況
公司收入
產品
最新動態

Sun Pharmaceutical

公司概況
公司收入
產品
最新動態

Ionis Pharmaceuticals Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11216729

The global demand for Amyotrophic Lateral Sclerosis Treatment Market is presumed to reach the market size of nearly USD 1344.28 Million by 2032 from USD 773.07 Million in 2023 with a CAGR of 6.34% under the study period 2024-2032.

Amyotrophic lateral sclerosis is an accelerating neurodegenerative illness in which nerve cells that regulate voluntary muscles in the central nervous system die. In nearly half of ALS cases, individuals lose the ability to swallow, breathe, speak, walk, and use their hands. Amyotrophic lateral sclerosis is incurable, and no effective treatment can slow or stop its course. Although no treatment can undo the damage caused by amyotrophic lateral sclerosis, it can make people feel more at ease and independent by reducing the progression of symptoms, preventing complications, and improving their overall quality of life. ALS can be treated with physical and occupational therapy, communication assistance, nutritional support, and breathing support.

MARKET DYNAMICS

Adopting a sedentary lifestyle raises the chance of acquiring the disease in the elderly, necessitating the development of new medications and tailored treatment alternatives. These factors are projected to propel the market for amyotrophic lateral sclerosis treatments higher. Growth in the prevalence of amyotrophic lateral sclerosis disease is expected to drive the global amyotrophic lateral sclerosis therapy market. However, the market is expected to be impeded by high treatment costs, a lack of understanding regarding amyotrophic lateral sclerosis disease, and restricted therapy alternatives.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Amyotrophic Lateral Sclerosis Treatment. The growth and trends of Amyotrophic Lateral Sclerosis Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Amyotrophic Lateral Sclerosis Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment

Medication
Stem Cell Therapy
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Amyotrophic Lateral Sclerosis Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Amyotrophic Lateral Sclerosis Treatment market include Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Co. Ltd., BrainStorm Therapeutics, Biogen Inc., Corestem, AB Science, F.Hoffmann-La Roche AG, Biohaven Pharmaceutical, Sun Pharmaceutical, Ionis Pharmaceuticals Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. AMYOTROPHIC LATERAL SCLEROSIS TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET ANALYSIS BY TREATMENT

5.1. Overview By Treatment
5.2. Historical and Forecast Data Analysis By Treatment
5.3. Medication Historic and Forecast Sales By Regions
5.4. Stem Cell Therapy Historic and Forecast Sales By Regions
5.5. Others Historic and Forecast Sales By Regions

6. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

6.1. Overview By Distribution Channel
6.2. Historical and Forecast Data Analysis By Distribution Channel
6.3. Hospital Pharmacies Historic and Forecast Sales By Regions
6.4. Retail Pharmacies Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE AMYOTROPHIC LATERAL SCLEROSIS TREATMENT COMPANIES

8.1. Amyotrophic Lateral Sclerosis Treatment Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF AMYOTROPHIC LATERAL SCLEROSIS TREATMENT INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Mitsubishi Tanabe Pharma Corporation
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Otsuka Pharmaceutical Co. Ltd.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. BrainStorm Therapeutics
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Biogen Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Corestem
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. AB Science
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. F.Hoffmann-La Roche AG
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Biohaven Pharmaceutical
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Sun Pharmaceutical
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Ionis Pharmaceuticals Inc
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Treatment (USD MN)
Medication Market Sales By Geography (USD MN)
Stem Cell Therapy Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Analysis By Distribution Channel (USD MN)
Hospital Pharmacies Market Sales By Geography (USD MN)
Retail Pharmacies Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Amyotrophic Lateral Sclerosis Treatment Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition